Pretreatment samples from 76 patients with BRAFV600E-positive metastatic melanoma who were treated with the BRAF inhibitors vemurafenib (n = 67) or dabrafenib (n = 9) were retrospectively analyzed by NGS. The gene discussed is BRAF; the disease is metastatic melanoma.